About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Mihalis S. Lionakis, Senior Investigator, Deputy Chief, Laboratory of Clinical Immunology & Microbiology (LCIM) - Chief, Fungal Pathogenesis Section, LCIM National Institute of Allergy & Infectious Diseases (NIAID), NIH
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a life-threatening monogenic multiorgan autoimmune syndrome caused by AIRE deficiency that impairs central immune tolerance. In this lecture, Dr. Lionakis will discuss findings from the prospective clinical and research evaluation of ~200 APECED patients enrolled at the NIH Clinical Center and corroborating mechanistic studies in the Aire-deficient mouse model. Collectively, these findings provide novel insights into redefined diagnostic criteria, immunopathogenesis, and targeted therapeutic intervention
Host: Dr. Pere Soler Palacín, Paediatric Infectious Diseases and Immunodeficiencies Unit, Children's Hospital and Woman's Hospital. Head of group, Infection and immunity in pediatric patients. Vall Hebron Institut de Recerca
Registre Online: https://gencat.zoom.us/j/92144038494
